[144] Semler Scientific, Inc. SEC Filing

Rhea-AI Filing Summary

Semler Scientific (SMLR) reported a Form 144 notice showing a proposed sale of 60,000 common shares through APEX CLEARING on the NASDAQ with an aggregate market value of $1,847,400.00. The filing states the shares were acquired and are being sold on 08/25/2025 via exercise of stock options from Semler Scientific, Inc., and lists 14,804,693 shares outstanding for the company. The filer certifies they are not aware of undisclosed material adverse information about the issuer. No other sales in the past three months were reported.

Positive

• Timely regulatory disclosure of proposed sale under Rule 144
• Full certification that the filer is not aware of undisclosed material adverse information
• No prior sales by the filer in the past three months were reported

Negative

• Insider liquidity event: exercise of options and immediate sale totaling $1,847,400
• Sizable single-day sale representing approximately 0.41% of outstanding shares (60,000 of 14,804,693)

Insights

Securities Analyst

TL;DR: Insider option exercise and immediate sale of 60,000 shares totaling $1.85M; routine disclosure with limited standalone impact.

The Form 144 documents an insider exercising options and proposing to sell all resulting shares the same day, generating proceeds of about $1.85 million. The sale equals roughly 0.41% of the reported outstanding shares (60,000 of 14,804,693), which is a modest dilution/turnover relative to total float. The filing is a standard compliance disclosure and does not itself convey operational performance or new company-specific information beyond the insider liquidity event. Investors should view this as a transparency item rather than a direct indicator of company fundamentals.

Corporate Governance Expert

TL;DR: The filing is procedurally complete and includes the required certification; the simultaneous exercise-and-sale pattern is common but worth noting for governance context.

The notice confirms the filer represented no undisclosed material adverse facts and follows Rule 144 reporting conventions. Exercising options and filing Form 144 for an immediate sale is a common mechanism for insiders to realize gains. While not a governance red flag by itself, repeated or large-scale insider sales without accompanying disclosure of intent or trading plans could attract scrutiny. This single filing shows compliance but does not provide further governance signals.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	APEX CLEARING 350 N ST. PAUL ST SUITE 300 DALLAS TX 75201	60000	1847400.00	14804693	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2025	Stock Option Exercise	SEMLER SCIENTIFIC, INC.			60000	08/25/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Semler Scientific's (SMLR) Form 144 filed on 08/25/2025 report?

The Form 144 reports a proposed sale of 60,000 common sharesstock option exercise and to be sold via APEX CLEARING on 08/25/2025 with aggregate market value of $1,847,400.00.

How many shares outstanding does Semler Scientific report on the Form 144?

The filing lists 14,804,693 shares outstanding.

Did the filer report any other securities sales in the past three months?

No. The Form 144 indicates Nothing to Report for securities sold during the past three months.

Through which broker will the SMLR shares be sold?

The filing lists APEX CLEARING, 350 N St. Paul St, Suite 300, Dallas, TX as the broker of record.

Does the filer assert any undisclosed material information about Semler Scientific?

By signing the notice, the filer represents they do not know any material adverse information